Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$205.14
-0.5%
$213.69
$176.57
$244.81
$364.44B0.326.73 million shs7.29 million shs
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
$88.21
+2.2%
$87.60
$74.54
$99.33
$69.26B0.315.44 million shs5.77 million shs
Chevron Corporation stock logo
CVX
Chevron
$185.30
-3.8%
$193.27
$133.77
$214.71
$383.79B0.5110.36 million shs11.07 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$113.53
+0.3%
$117.31
$73.31
$125.14
$279.46B0.189.73 million shs7.25 million shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-0.48%+0.46%-0.72%-6.09%+9.51%
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
+2.16%+4.38%+4.30%-7.00%-3.12%
Chevron Corporation stock logo
CVX
Chevron
-3.82%-3.52%-6.84%+3.40%+36.38%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+0.28%+2.58%-6.06%-5.09%+43.51%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$205.14
-0.5%
$213.69
$176.57
$244.81
$364.44B0.326.73 million shs7.29 million shs
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
$88.21
+2.2%
$87.60
$74.54
$99.33
$69.26B0.315.44 million shs5.77 million shs
Chevron Corporation stock logo
CVX
Chevron
$185.30
-3.8%
$193.27
$133.77
$214.71
$383.79B0.5110.36 million shs11.07 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$113.53
+0.3%
$117.31
$73.31
$125.14
$279.46B0.189.73 million shs7.25 million shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-0.48%+0.46%-0.72%-6.09%+9.51%
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
+2.16%+4.38%+4.30%-7.00%-3.12%
Chevron Corporation stock logo
CVX
Chevron
-3.82%-3.52%-6.84%+3.40%+36.38%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+0.28%+2.58%-6.06%-5.09%+43.51%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.85
Moderate Buy$252.9023.29% Upside
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
2.67
Moderate Buy$95.888.69% Upside
Chevron Corporation stock logo
CVX
Chevron
2.76
Moderate Buy$202.709.39% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.68
Moderate Buy$128.1812.90% Upside

Current Analyst Ratings Breakdown

Latest CVX, CL, MRK, and ABBV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2026
Chevron Corporation stock logo
CVX
Chevron
Reiterated RatingBuy$216.00
5/6/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Initiated CoverageNeutral$125.00
5/5/2026
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
Boost Price TargetEqual Weight$79.00 ➝ $80.00
5/5/2026
Chevron Corporation stock logo
CVX
Chevron
Reiterated RatingOutperform$220.00
5/4/2026
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
UpgradeHold (C)Hold (C+)
5/4/2026
Chevron Corporation stock logo
CVX
Chevron
Boost Price TargetBuy$218.00 ➝ $220.00
5/4/2026
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
Boost Price TargetBuy$98.00 ➝ $100.00
5/4/2026
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
Reiterated RatingBuy$99.00
5/4/2026
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
Reiterated RatingOverweight
5/4/2026
Chevron Corporation stock logo
CVX
Chevron
Boost Price TargetEqual Weight$180.00 ➝ $192.00
5/4/2026
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
Boost Price TargetOverweight$95.00 ➝ $96.00
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$61.16B5.93$15.07 per share13.61($1.83) per share-112.10
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
$20.80B3.40$5.76 per share15.31$0.61 per share144.60
Chevron Corporation stock logo
CVX
Chevron
$189.03B1.95$16.07 per share11.53$95.44 per share1.94
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$65.01B4.31$11.46 per share9.91$18.60 per share6.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.23B$2.03101.0512.620.715.79%-911.57%13.43%N/A
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
$2.13B$2.5734.3221.784.4710.04%386.76%17.89%N/A
Chevron Corporation stock logo
CVX
Chevron
$12.30B$5.7732.1115.280.715.79%7.01%4.16%N/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$18.25B$3.5531.9811.532.2413.59%27.55%10.73%N/A

Latest CVX, CL, MRK, and ABBV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2026Q1 2026
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
$0.9430$0.97+$0.0270$0.80$5.22 billion$5.32 billion
5/1/2026Q1 2026
Chevron Corporation stock logo
CVX
Chevron
$1.00$1.41+$0.41$1.11$51.86 billion$48.61 billion
4/30/2026Q1 2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-$1.47-$1.28+$0.19-$1.72$15.85 billion$16.29 billion
4/29/2026Q1 2026
AbbVie Inc. stock logo
ABBV
AbbVie
$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.923.37%+6.80%340.89%53 Years
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
$2.122.40%+3.31%82.49%63 Years
Chevron Corporation stock logo
CVX
Chevron
$7.123.84%+5.80%123.40%38 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.402.99%+5.75%95.77%14 Years

Latest CVX, CL, MRK, and ABBV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/29/2026
Chevron Corporation stock logo
CVX
Chevron
quarterly$1.783.73%5/19/20265/19/20266/10/2026
2/19/2026
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.733.32%4/15/20264/15/20265/15/2026
3/12/2026
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
quarterly$0.532.54%4/20/20264/20/20265/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
N/A
0.67
0.56
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
16.33
1.02
0.29
Chevron Corporation stock logo
CVX
Chevron
0.21
1.15
0.86
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1.02
1.30
1.30

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
80.41%
Chevron Corporation stock logo
CVX
Chevron
72.42%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.06%
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
0.43%
Chevron Corporation stock logo
CVX
Chevron
0.56%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
57,0001.77 billion1.77 billionOptionable
Colgate-Palmolive Company stock logo
CL
Colgate-Palmolive
33,600802.30 million798.85 millionOptionable
Chevron Corporation stock logo
CVX
Chevron
43,0391.99 billion1.98 billionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.47 billion2.47 billionOptionable

Recent News About These Companies

BMO Capital Remains a Buy on Merck & Company (MRK)
MSD concludes Terns acquisition to expand CML pipeline
Bokf Na Sells 28,321 Shares of Merck & Co., Inc. $MRK

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$205.14 -0.97 (-0.47%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$204.69 -0.45 (-0.22%)
As of 09:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Colgate-Palmolive stock logo

Colgate-Palmolive NYSE:CL

$88.21 +1.88 (+2.17%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$88.40 +0.20 (+0.23%)
As of 09:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Chevron stock logo

Chevron NYSE:CVX

$185.30 -7.34 (-3.81%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$182.14 -3.16 (-1.71%)
As of 09:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$113.53 +0.38 (+0.33%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$113.43 -0.10 (-0.09%)
As of 09:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.